5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3'] bipyridinyl in pure crystalline form and process for synthesis.

摘要

This invention encompasses the Form V polymorph of Compound A of structural formula (A) which is useful in the treatment of cyclooxygenase-2 mediated diseases. The invention encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising the Form V polymorph of Compound A. The invention also encompasses a process for synthesizing the Form V polymorph of Compound A.